Perrigo Company plc (PRGO) | Financial Analysis & Statements
Perrigo Company plc Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
1.1B
Gross Profit
362.2M
32.64%
Operating Income
84.4M
7.61%
Net Income
-1.4B
-127.80%
Balance Sheet Metrics
Total Assets
8.5B
Total Liabilities
5.6B
Shareholders Equity
2.9B
Debt to Equity
1.91
Cash Flow Metrics
Operating Cash Flow
-1.2B
Free Cash Flow
148.6M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Perrigo Company plc Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 4.3B | 4.4B | 4.7B | 4.5B | 4.1B |
| Cost of Goods Sold | 2.8B | 2.8B | 3.0B | 3.0B | 2.7B |
| Gross Profit | 1.5B | 1.5B | 1.7B | 1.5B | 1.4B |
| Gross Margin % | 35.1% | 35.3% | 36.1% | 32.7% | 34.2% |
| Operating Expenses | |||||
| Research & Development | 95.4M | 112.2M | 122.5M | 123.1M | 122.0M |
| Selling, General & Administrative | 1.1B | 1.1B | 1.3B | 1.2B | 1.1B |
| Other Operating Expenses | 30.5M | 6.0M | -800.0K | 800.0K | -417.6M |
| Total Operating Expenses | 1.2B | 1.2B | 1.4B | 1.3B | 815.8M |
| Operating Income | 312.8M | 311.9M | 284.1M | 121.4M | 600.4M |
| Operating Margin % | 7.4% | 7.1% | 6.1% | 2.7% | 14.5% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | - |
| Interest Expense | 162.5M | 187.8M | 173.8M | 156.0M | 125.0M |
| Other Non-Operating Income | -1.4B | -204.8M | -118.6M | -104.5M | -216.7M |
| Pre-tax Income | -1.3B | -80.7M | -8.3M | -139.1M | 258.7M |
| Income Tax | 104.4M | 80.0M | -3.9M | -8.2M | 389.6M |
| Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% | 150.6% |
| Net Income | -1.4B | -171.8M | -12.7M | -140.6M | -68.9M |
| Net Margin % | -33.5% | -3.9% | -0.3% | -3.2% | -1.7% |
| Key Metrics | |||||
| EBITDA | 637.1M | 638.7M | 654.0M | 406.9M | 885.9M |
| EPS (Basic) | $-10.29 | $-1.25 | $-0.09 | $-1.04 | $-0.52 |
| EPS (Diluted) | $-10.29 | $-1.25 | $-0.09 | $-1.04 | $-0.52 |
| Basic Shares Outstanding | 138500000 | 137400000 | 135300000 | 134500000 | 133600000 |
| Diluted Shares Outstanding | 138500000 | 137400000 | 135300000 | 134500000 | 133600000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Perrigo Company plc Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 531.6M | 558.8M | 751.3M | 600.7M | 1.9B |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 612.8M | 642.3M | 739.6M | 697.1M | 652.9M |
| Inventory | 1.1B | 1.1B | 1.1B | 1.2B | 1.0B |
| Other Current Assets | 231.4M | 199.0M | 201.1M | 271.8M | 305.8M |
| Total Current Assets | 2.8B | 2.5B | 2.8B | 2.7B | 3.9B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 167.8M | 175.2M | 183.6M | 217.1M | 166.9M |
| Goodwill | 6.5B | 9.1B | 10.0B | 10.3B | 8.2B |
| Intangible Assets | 2.4B | 2.4B | 3.0B | 3.3B | 2.2B |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 265.1M | 323.7M | 361.0M | 374.8M | 384.0M |
| Total Non-Current Assets | 5.7B | 7.2B | 8.0B | 8.3B | 6.6B |
| Total Assets | 8.5B | 9.6B | 10.8B | 11.0B | 10.4B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 474.5M | 495.2M | 477.7M | 537.3M | 411.2M |
| Short-term Debt | 36.6M | 36.4M | 440.6M | 36.2M | 629.8M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 26.8M | - | - | 101.3M | 49.1M |
| Total Current Liabilities | 1.0B | 1.0B | 1.6B | 1.1B | 1.6B |
| Non-Current Liabilities | |||||
| Long-term Debt | 3.6B | 3.6B | 3.6B | 4.1B | 3.1B |
| Deferred Tax Liabilities | 168.9M | 203.2M | 262.3M | 368.2M | 239.3M |
| Other Non-Current Liabilities | 814.3M | 499.2M | 559.8M | 623.0M | 382.8M |
| Total Non-Current Liabilities | 4.6B | 4.3B | 4.5B | 5.1B | 3.7B |
| Total Liabilities | 5.6B | 5.3B | 6.0B | 6.2B | 5.3B |
| Equity | |||||
| Common Stock | 6.6B | 6.7B | 6.8B | 6.9B | 7.0B |
| Retained Earnings | -3.7B | -2.3B | -2.1B | -2.1B | -1.9B |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 2.9B | 4.3B | 4.8B | 4.8B | 5.2B |
| Key Metrics | |||||
| Total Debt | 3.6B | 3.6B | 4.1B | 4.1B | 3.7B |
| Working Capital | 1.8B | 1.4B | 1.2B | 1.6B | 2.3B |
Balance Sheet Composition
Perrigo Company plc Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -1.4B | -171.8M | -12.7M | -140.6M | -68.9M |
| Depreciation & Amortization | 337.5M | 325.9M | 359.5M | 338.6M | 312.2M |
| Stock-Based Compensation | 54.6M | 64.4M | 68.8M | 54.9M | 60.1M |
| Working Capital Changes | -59.3M | 58.3M | -70.1M | 58.9M | -174.7M |
| Operating Cash Flow | -1.1B | 385.9M | 308.0M | 306.8M | 151.4M |
| Investing Activities | |||||
| Capital Expenditures | -93.4M | -118.3M | -101.7M | -96.4M | -152.1M |
| Acquisitions | 14.4M | 215.5M | 0 | -2.0B | 1.5B |
| Investment Purchases | 0 | -48.2M | - | - | - |
| Investment Sales | - | - | 0 | 61.7M | 0 |
| Investing Cash Flow | -81.0M | 73.6M | -97.3M | -2.0B | 1.3B |
| Financing Activities | |||||
| Share Repurchases | - | - | - | 0 | 0 |
| Dividends Paid | -159.3M | -152.5M | -149.7M | -142.4M | -129.6M |
| Debt Issuance | 0 | 1.1B | 295.1M | 1.6B | 0 |
| Debt Repayment | -34.8M | -1.5B | -325.3M | -970.6M | -30.6M |
| Financing Cash Flow | -220.5M | -611.0M | -187.2M | 409.9M | -209.3M |
| Free Cash Flow | 145.1M | 244.6M | 303.8M | 210.9M | 4.2M |
| Net Change in Cash | -1.4B | -151.5M | 23.5M | -1.2B | 1.2B |
Cash Flow Trend
Perrigo Company plc Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
2,818.00
Forward P/E
4.93
Price to Book
0.55
Price to Sales
0.38
PEG Ratio
0.91
Profitability Ratios
Profit Margin
-33.51%
Operating Margin
10.20%
Return on Equity
-38.66%
Return on Assets
2.35%
Financial Health
Current Ratio
2.76
Debt to Equity
131.16
Beta
0.49
Per Share Data
EPS (TTM)
$-10.12
Book Value per Share
$21.33
Revenue per Share
$30.71
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| PRGO | 1.6B | 2,818.00 | 0.55 | -38.66% | -33.51% | 131.16 |
| Zoetis | 49.8B | 19.58 | 15.04 | 65.99% | 28.24% | 279.59 |
| Haleon Plc - ADR | 42.4B | 18.72 | 1.88 | 10.27% | 15.11% | 52.37 |
| Dynavax Technologies | 1.8B | 54.60 | 3.41 | -7.14% | -13.13% | 54.15 |
| Ani Pharmaceuticals | 1.8B | 24.08 | 3.10 | 16.16% | 8.87% | 116.19 |
| Harrow | 1.4B | -277.07 | 27.78 | -8.47% | -1.89% | 483.72 |
Financial data is updated regularly. All figures are in the company's reporting currency.






